WELL Program for Depression Prevention in Bereaved Older Adults

(WELL Trial)

st
EC
Overseen ByEmilee Croswell
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores ways to prevent major depression in older adults who have recently lost their spouse. Researchers compare two approaches: one group uses digital tools to track sleep, meals, and physical activity, paired with motivational health coaching, while the other receives enhanced usual care (a standard care approach with added assessments). The goal is to determine if these lifestyle adjustments can help manage depressive symptoms by influencing daily activity patterns. The trial seeks individuals aged 60 and older who have lost their spouse within the last year and are experiencing signs of depression but do not have a current diagnosis of major depression or other severe mental health conditions.

As an unphased trial, this study offers participants the chance to contribute to innovative research aimed at improving mental health care for older adults.

Do I need to stop my current medications to join the trial?

If you are taking new medications for depression, like antidepressants or benzodiazepines, more than four days a week for over two months, you might not be eligible. However, if you've been on a stable dose for at least a month and agree not to change it during the trial, you can participate.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that the WELL program, which aids older adults who have lost a spouse in adopting healthy lifestyles, is generally safe. Previous studies found that digital tools for tracking sleep, meals, and exercise, combined with motivational coaching, are well-received by participants. No serious side effects have been reported. The program aims to support mental health by promoting healthy habits and is designed to be low-risk. Although the WELL program is still under study, its methods rely on widely accepted health practices, suggesting it is likely safe.12345

Why are researchers excited about this trial?

Researchers are excited about the WELL Program because it offers a fresh approach to preventing depression in bereaved older adults by integrating lifestyle changes with digital monitoring. Unlike traditional treatments that might rely on medication or therapy alone, the WELL Program emphasizes holistic health by tracking sleep, meals, and physical activity, coupled with motivational health coaching and personalized feedback. This method not only supports mental health but also encourages overall well-being, providing a comprehensive strategy to help widowed elders navigate their loss.

What evidence suggests that this trial's treatments could be effective for preventing depression in bereaved older adults?

Research has shown that the WELL program, one of the treatments in this trial, uses digital tools and motivational health coaching to help older adults avoid depression after losing a spouse. Early results suggest this program can boost mental health by promoting healthy habits like regular sleep, balanced meals, and exercise. Maintaining a steady routine of activity and rest is important, as it affects mood and emotional well-being. Some studies indicate that these methods can lower the risk of major depression in older adults who have lost a spouse. While more research is underway, initial signs are positive for the WELL program's effect on mental health in this situation. Participants in this trial may receive either the WELL program or Enhanced Usual Care, which serves as a comparator.15678

Who Is on the Research Team?

st

Sarah Stahl, PhD

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for people aged 60 or older who have recently lost a spouse and are showing signs of depression, but do not yet have major depression. They should not be experiencing severe cognitive issues, taking new mood-stabilizing medications post-bereavement, or have had psychosis in the last year.

Inclusion Criteria

I lost my spouse or partner within the last year, including due to COVID-19.
I am at risk for depression but do not currently have depression, PTSD, or complex bereavement disorder.
I am 60 years old or older.

Exclusion Criteria

You are currently at high risk of attempting suicide according to a specific protocol used to manage suicide risk.
I've been on stable doses of depression medication for over a month after my spouse's death.
dementia/cognitive impairment; Telephone Interview Cognitive Screening (TICS) <19;
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomly assigned to either self-monitor sleep, meals, and physical activity for 12 weeks using digital monitoring plus motivational health coaching or receive enhanced usual care.

12 weeks
Baseline, months 1 & 2, post-intervention

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 3, 6, 12, and 18 months post-intervention.

18 months
3, 6, 12, 18 months post-intervention

What Are the Treatments Tested in This Trial?

Interventions

  • Enhanced Usual Care
  • WIdowed Elders' LIfestyle after Loss (WELL)
Trial Overview The study tests two approaches to prevent depression: WELL involves self-monitoring sleep, meals, physical activity with health coaching; EUC is usual care plus assessments. Participants will be randomly assigned to one of these groups and followed up for up to 18 months.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Widowed Elders' Lifestyle after Loss (WELL)Experimental Treatment1 Intervention
Group II: Enhanced Usual CareActive Control1 Intervention

Enhanced Usual Care is already approved in United States, European Union, China for the following indications:

🇺🇸
Approved in United States as Lactulose for:
🇪🇺
Approved in European Union as Lactulose for:
🇨🇳
Approved in China as Lactulose for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Citations

1.samhsa.govsamhsa.gov/
Home | SAMHSA - Substance Abuse and Mental Health ...SAMHSA leads efforts to advance behavioral health across the U.S., offering resources for mental health, substance use, and community well-being.
Outcomes of Bereavement Care Among Widowed Older ...Bereavement is common among older adults and may result in major depression or complicated grief (CG). Little is known about the effectiveness of physician ...
Promoting Widowed Elders Lifestyle After LossDetails for study NCT02631291, | ClinicalTrials.gov.
Design and rationale for a technology-based healthy ...... prevention intervention pilot study focused on older adults who are grieving the loss of a loved one, entitled “Widowed Elders' Lifestyle after Loss” (WELL).
Pitt Launches New Study to Prevent Depression in Older ...... Widowed Elders Lifestyle after Loss, or WELL, a depression prevention study for older adults who are grieving the loss of a spouse or life ...
Effect of Spousal Loss on Depression in Older AdultsThis study explored the factors affecting depression among widowed older adults to provide health care strategies for successful aging.
Widowed Elders' Lifestyle after Loss (WELL)Provides essential data on many key topics including income and poverty, work and retirement, neighborhoods and housing, transportation, physical health.
Changes in Routine Health Behaviors Following Late-life ...This systematic review examines the relationship between late-life spousal bereavement and changes in routine health behaviors.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security